Site Search

Displaying results 31 - 40 of 893

Vaccine trials for hospital superbugs need a radical rethink

News | 12/10/2021 |

News

A history of failure should not discourage new research. What we need is a new strategy, says Isabelle Bekeredjian-Ding, Head of Microbiology at Paul-Ehrlich-Institut and member of the IMI Scientific Committee

Image by Viacheslav Nikolaenko via Shutterstock

116th Edition – October 2021

Newsletter Issue | October 2021

Table of contents:

Antibiotics economics: rapid tests are worth it when confidence is low

News | 07/10/2021 |

News

Fighting drug-resistant bacteria requires prescribing fewer antibiotics. VALUE-DX lay out the economic calculations behind decisions to use point-of-care tests.

Closing in on COVID: results from the first year of CARE

News | 05/10/2021 |

News

Success stories from projects

Multiple studies from the CARE project teach us more about how COVID19 wreaks havoc, and how it might be defeated.

IMI impact on paediatric medicine

News | 04/10/2021 |

News

Medical innovation has often been slow to trickle down to children and adolescents, and IMI's paediatric research portfolio is changing that.

IMI impact on paediatric medicine - Event

Event | 10/11/2021 | Online, Virtual event

About this event For a long time, paediatric medicine development has largely been neglected, meaning that drugs used in children have not been appropriately tested in paediatric populations. However, European legislation introduced more than 10 years ago, as well as equivalent ...

INNODIA Young Scientist Award: exciting science, explained with clarity

News | 30/09/2021 |

News

The prize is intended to encourage young scientists, and to spread the word about INNODIA and INNODIA diabetes research

Publications from IMI projects are cited at twice the global average rate

News | 29/09/2021 |

News

Two thirds of IMI project publications appeared in high-impact journals, and more than half were the result of international author collaborations.

Data suggest four categories of trajectories in people at risk of dementia

News | 28/09/2021 |

News

Success stories from projects

EPAD’s computational models, working on geographically-diverse, high-quality datasets, help identify subgroups in cognitive function evolution.

PERSIST-SEQ to probe rare cancer cells behind drug resistance

News | 23/09/2021 |

News

New IMI project PERSIST-SEQ will study the rare cancer cells that survive drug treatments.

A patient receiving chemotherapy. Image by Chaikom via Shutterstock